ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in ENDRA Life Sciences Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q2 2021
- Shares held
- 3.50M
- −53.6K (−1.5%) vs. Q2 2021
- Total value
- $6.06M
- −$1.69M (−21.8%) vs. Q2 2021
- New holders
- 2
- 4 more added
- Sold out
- 5
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,713,828 | $2.96M | 0.00% | +4,728+0.3% | Added |
| GWM Advisors LLC | 705,347 | $1.22M | 0.03% | −920.0% | Reduced |
| Geode Capital Management, LLC | 323,679 | $559.0K | 0.00% | +7,197+2.3% | Added |
| Morgan Stanley | 232,312 | $402.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 103,802 | $180.0K | 0.00% | −2,200−2.1% | Reduced |
| State Street Corp | 96,500 | $167.0K | 0.00% | +36,200+60.0% | Added |
| 55I, LLC | 88,850 | $154.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 63,378 | $110.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 44,037 | $76.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 35,000 | $61.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 28,208 | $49.0K | 0.00% | −1,591−5.3% | Reduced |
| Ieq Capital, LLC | 17,111 | $30.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 15,310 | $26.0K | 0.00% | −10,000−39.5% | Reduced |
| Citadel Advisors LLC | 15,264 | $26.0K | 0.00% | +15,264 | New |
| Spire Wealth Management | 10,000 | $17.0K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 5,910 | $10.0K | 0.00% | −400−6.3% | Reduced |
| Wells Fargo & Company | 1,305 | $2.00K | 0.00% | +2+0.2% | Added |
| Geneos Wealth Management Inc. | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 240 | $0 | 0.00% | −89−27.1% | Reduced |
| Tower Research Capital LLC (TRC) | 50 | $0 | 0.00% | +50 | New |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −47,709−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −29,700−100.0% | Sold out |
| Tranquility Partners, LLC | 0 | $0 | 0.00% | −12,750−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −16−100.0% | Sold out |